Macrophage heterogeneity in renal inflammation

Nephrology Dialysis Transplantation

Volumn 18, Issue 10, 2003, Pages 1962-1965

  Erwig, Lars Peter ^a   Kluth, David C ^a   Rees, Andrew J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Activation; Glomerulonephritis; Inflammation; Macrophage

Indexed keywords

CELL INFILTRATION; DNA MODIFICATION; DRUG TARGETING; EDITORIAL; FETUS DEVELOPMENT; HOST RESISTANCE; HUMAN; IN VIVO STUDY; KIDNEY FUNCTION; KIDNEY INJURY; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE INJURY; TISSUE REPAIR; WOUND HEALING;

ANIMALS; GLOMERULONEPHRITIS; HUMANS; KIDNEY FUNCTION TESTS; MACROPHAGE ACTIVATION; MICE; PROGNOSIS; RATS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0141841772     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg313     Document Type: Editorial

References (24)

1. Erwig LP, Kluth DC, Rees AJ. Macrophages in renal inflammation. Curr Opin Nephrol Hypertens 2001; 10: 341-347
2. Freire-de-Lima CG, Nascimento DO, Soares MB et al. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 2000; 403: 199-203
3. Atkins RC, Holdsworth SR, Glasgow EF, Matthews FE. The macrophage in human rapidly progressive glomerulonephritis. Lancet 1976; 1: 830-832
4. Holdsworth SR, Neale TJ, Wilson CB. Abrogation of macrophage-dependent injury in experimental glomerulonephritis in the rabbit. Use of an anti-macrophage serum. J Clin Invest 1981; 68: 686
5. Ikezumi Y, Hurst LA, Masaki T, Atkins RC, Nikolic-Paterson DJ. Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation. Kidney Int 2003; 63: 83-95
6. Rastaldi M, Ferrario F, Crippa A et al. Glomerular monocyte-macrophage features in ANCA-positive renal vasculitis and cryoglobulinemic nephritis. J Am Soc Nephrol 2000; 11: 2036-2043
7. Segerer S, Mack M, Regele H, Kerjaschki D, Schlondorff D. Expression of the C-C chemokine receptor 5 in human kidney diseases. Kidney Int 1999; 56: 52-64
8. Topham PS, Csizmadia V, Soler D et al. Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis. J Clin Invest 1999; 104: 1549-1557
9. Bird JE, Giancarli MR, Kurihara T et al. Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice. Kidney Int 2000; 57: 129-136
10. Henson PM, Riches DW. Modulation of macrophage maturation by cytokines and lipid mediators: a potential role in resolution of pulmonary inflammation. Ann NY Acad Sci 1994; 725: 298-308
11. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23-35
12. Ehrt S, Schnappinger D, Bekiranov S et al. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J Exp Med 2001; 194: 1123-1140
13. Anderson CF, Mosser DM. A novel phenotype for an activated macrophage: the type 2 activated macrophage. J Leukocyte Biol 2002; 72: 101-106
14. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765
15. Riches D. Signalling heterogeneity as a contributing factor in macrophage functional diversity. Semin Cell Biol 1995; 6: 377-384
16. Erwig LP, Kluth DC, Walsh GM, Rees AJ. Initial cytokine exposure determines macrophage function and renders them unresponsive to other cytokines. J Immunol 1998; 161: 1983-1998
17. Erwig LP, Stewart K, Rees AJ. Macrophages from inflamed but not normal glomeruli are unresponsive to anti-inflammatory cytokines. Am J Pathol 2000; 156: 295-301
18. Wilson HM, Minto AW, Brown PA, Erwig LP, Rees AJ. Transforming growth factor-beta isoforms and glomerular injury in nephrotoxic nephritis. Kidney Int 2000; 57: 2434-2444
19. Robertson MJ, Erwig LP, Liversidge J, Forrester JV, Rees AJ, Dick AD. Retinal micro-environment controls resident and infiltrating macrophage function during uveoretinitis. Invest Ophthalmol Vis Sci 2002; 43: 2250-2257
20. Minto AWM, Erwig LP, Rees AJ. Heterogeneity of macrophage activation in anti-Thy 1.1 nephritis. Am J Pathol 2003; in press
21. Yamagishi H, Yokoo T, Imasawa T, Mitarai T, Kawamura T, Utsunomiya Y. Genetically modified bone marrow-derived vehicle cells site specifically deliver an anti-inflammatory cytokine to inflamed interstitium of obstructive nephropathy. J Immunol 2001; 166: 609-616
22. Yokoo T, Ohashi T, Utsunomiya Y et al. Prophylaxis of antibody-induced acute glomerulonephritis with genetically modified bone marrow-derived vehicle cells. Hum Gene Ther 1999; 10: 2673-2678
23. Kluth DC, Ainslie CV, Pearce WP et al. Macrophages transfected with adenovirus to express IL-4 reduce inflammation in experimental glomerulonephritis. J Immunol 2001; 166: 4728-4736
24. Wilson HM, Stewart KN, Brown PA et al. Bone-marrow-derived macrophages genetically modified to produce IL-10 reduce injury in experimental glomerulonephritis. Mol Ther 2002; 6: 710-717